tonsilla compositum injektionslösung
ebi-pharm ag - tonsilla d28, säure ascorbicum d6, das hauptproblem unsane deren d8, knochenmark knochen rot, ihre d10, schnur umbilicalis d10, splen d10, der hypothalamus d10 -, leber-d10, embryo ihrer d13, cortex drüsen suprarenalis ihrer d13, cortisoni acetas d13, pulsatilla pratensis d6, säure l(+) lacticum d6, echinacea d4, calcium phosphas d10, aesculus hippocastanum d6, kalii stibyli tartras d6, kartoffel, dulcamara d4, levothyroxinum d13, dactylopius coccus d6, bügeleisen, phosphoricum d10, gentiana gelb d6, gerani - injektionslösung - tonsilla d28, säure ascorbicum d6, das hauptproblem unsane deren d8, knochenmark knochen rot, ihre d10, schnur umbilicalis d10, splen d10, der hypothalamus d10 -, leber-d10, embryo ihrer d13, cortex drüsen suprarenalis ihrer d13, cortisoni acetas d13, pulsatilla pratensis d6, säure l(+) lacticum d6, echinacea d4, calcium phosphas d10, aesculus hippocastanum d6, kalii stibyli tartras d6, kartoffel, dulcamara d4, levothyroxinum d13, dactylopius coccus d6, bügeleisen, phosphoricum d10, gentiana gelb d6, geranium robertianum d6, quecksilber löslich hahnemanni d13, barii carbonas d28, conium unreine d4 aparine d6, sulfur d8 ana teile, natrii chloridum, aqua ad iniectabilia, für glas. - ohne indikation - homöopathische arzneimittel
tocodilydrin retardkapsel
swiss-pharma gmbh - bupheninhydrochlorid - retardkapsel - bupheninhydrochlorid 15.mg
penitardon kapsel
rhône-poulenc rorer gmbh - bupheninhydrochlorid - kapsel - bupheninhydrochlorid 15.mg
opino n gel spezial
biomo pharma gmbh - geschäftsanschrift - - bupheninhydrochlorid, aescin - gel - bupheninhydrochlorid 10.mg; aescin 10.mg
dilatol lösung
gepepharm gmbh - bupheninhydrochlorid - lösung - bupheninhydrochlorid 4.mg
dilatol tablette
gepepharm gmbh - bupheninhydrochlorid - tablette - bupheninhydrochlorid 6.mg
arbid retard dragees
troponwerke gmbh & co. kommanditgesellschaft - bupheninhydrochlorid, diphenylpyralinhydrochlorid - dragees - bupheninhydrochlorid 6.5mg; diphenylpyralinhydrochlorid 6.5mg
lonsurf
les laboratoires servier - trifluridine, tipiracil hydrochloride - kolorektale neoplasmen - antineoplastische mittel - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.
inaqovi
otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - leukämie, myeloid - antineoplastische mittel - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.
apoplectal retard n retardkapsel
fujisawa deutschland gmbh - rosskastaniensamen, te mit ethanol/ethanol-wasser (%-angaben), bupheninhydrochlorid - retardkapsel - rosskastaniensamen, te mit ethanol/ethanol-wasser (%-angaben) 96.-116.mg; bupheninhydrochlorid 4.mg